Aytu BioPharma, Inc.: Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering
ENGLEWOOD, CO / ACCESSWIRE / August 15, 2022 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today